756 related articles for article (PubMed ID: 32785220)
1. Heterozygous knockout of Bile salt export pump ameliorates liver steatosis in mice fed a high-fat diet.
Okushin K; Tsutsumi T; Ikeuchi K; Kado A; Enooku K; Fujinaga H; Yamauchi N; Ushiku T; Moriya K; Yotsuyanagi H; Koike K
PLoS One; 2020; 15(8):e0234750. PubMed ID: 32785220
[TBL] [Abstract][Full Text] [Related]
2. Absence of Bsep/Abcb11 attenuates MCD diet-induced hepatic steatosis but aggravates inflammation in mice.
Fuchs CD; Krivanec S; Steinacher D; Mlitz V; Wahlström A; Stahlman M; Claudel T; Scharnagl H; Stojakovic T; Marschall HU; Trauner M
Liver Int; 2020 Jun; 40(6):1366-1377. PubMed ID: 32141703
[TBL] [Abstract][Full Text] [Related]
3. Dan-shen Yin promotes bile acid metabolism and excretion to prevent atherosclerosis via activating FXR/BSEP signaling pathway.
Sheng Y; Meng G; Zhang M; Chen X; Chai X; Yu H; Han L; Wang Q; Wang Y; Jiang M
J Ethnopharmacol; 2024 Aug; 330():118209. PubMed ID: 38663779
[TBL] [Abstract][Full Text] [Related]
4. The effect of fibroblast growth factor 15 deficiency on the development of high fat diet induced non-alcoholic steatohepatitis.
Schumacher JD; Kong B; Pan Y; Zhan L; Sun R; Aa J; Rizzolo D; Richardson JR; Chen A; Goedken M; Aleksunes LM; Laskin DL; Guo GL
Toxicol Appl Pharmacol; 2017 Sep; 330():1-8. PubMed ID: 28673684
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of ileal bile acid uptake protects against nonalcoholic fatty liver disease in high-fat diet-fed mice.
Rao A; Kosters A; Mells JE; Zhang W; Setchell KD; Amanso AM; Wynn GM; Xu T; Keller BT; Yin H; Banton S; Jones DP; Wu H; Dawson PA; Karpen SJ
Sci Transl Med; 2016 Sep; 8(357):357ra122. PubMed ID: 27655848
[TBL] [Abstract][Full Text] [Related]
6. Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease.
Jiang C; Xie C; Li F; Zhang L; Nichols RG; Krausz KW; Cai J; Qi Y; Fang ZZ; Takahashi S; Tanaka N; Desai D; Amin SG; Albert I; Patterson AD; Gonzalez FJ
J Clin Invest; 2015 Jan; 125(1):386-402. PubMed ID: 25500885
[TBL] [Abstract][Full Text] [Related]
7. The protective mechanism of Lactobacillus plantarum FZU3013 against non-alcoholic fatty liver associated with hyperlipidemia in mice fed a high-fat diet.
Chen M; Guo WL; Li QY; Xu JX; Cao YJ; Liu B; Yu XD; Rao PF; Ni L; Lv XC
Food Funct; 2020 Apr; 11(4):3316-3331. PubMed ID: 32226996
[TBL] [Abstract][Full Text] [Related]
8. CD47 Deficiency in Mice Exacerbates Chronic Fatty Diet-Induced Steatohepatitis Through Its Role in Regulating Hepatic Inflammation and Lipid Metabolism.
Tao HC; Chen KX; Wang X; Chen B; Zhao WO; Zheng Y; Yang YG
Front Immunol; 2020; 11():148. PubMed ID: 32158445
[TBL] [Abstract][Full Text] [Related]
9. Vitamin D deficiency promotes nonalcoholic steatohepatitis through impaired enterohepatic circulation in animal model.
Kong M; Zhu L; Bai L; Zhang X; Chen Y; Liu S; Zheng S; Pandol SJ; Han YP; Duan Z
Am J Physiol Gastrointest Liver Physiol; 2014 Nov; 307(9):G883-93. PubMed ID: 25214402
[TBL] [Abstract][Full Text] [Related]
10. H1-antihistamines exacerbate high-fat diet-induced hepatic steatosis in wild-type but not in apolipoprotein E knockout mice.
Raveendran VV; Kassel KM; Smith DD; Luyendyk JP; Williams KJ; Cherian R; Reed GA; Flynn CA; Csanaky IL; Lickteig AL; Pratt-Hyatt MJ; Klaassen CD; Dileepan KN
Am J Physiol Gastrointest Liver Physiol; 2014 Jul; 307(2):G219-28. PubMed ID: 24852568
[TBL] [Abstract][Full Text] [Related]
11. FXR Signaling-Mediated Bile Acid Metabolism Is Critical for Alleviation of Cholesterol Gallstones by
Ye X; Huang D; Dong Z; Wang X; Ning M; Xia J; Shen S; Wu S; Shi Y; Wang J; Wan X
Microbiol Spectr; 2022 Oct; 10(5):e0051822. PubMed ID: 36036629
[TBL] [Abstract][Full Text] [Related]
12. The effects of brewers' spent grain on high-fat diet-induced fatty liver.
Pei Y; Balogun O; Otieno D; Parks JS; Kang HW
Biochem Biophys Res Commun; 2022 Aug; 616():49-55. PubMed ID: 35636255
[TBL] [Abstract][Full Text] [Related]
13. Pu-erh tea extract ameliorates high-fat diet-induced nonalcoholic steatohepatitis and insulin resistance by modulating hepatic IL-6/STAT3 signaling in mice.
Cai X; Fang C; Hayashi S; Hao S; Zhao M; Tsutsui H; Nishiguchi S; Sheng J
J Gastroenterol; 2016 Aug; 51(8):819-29. PubMed ID: 26794005
[TBL] [Abstract][Full Text] [Related]
14. The intrahepatic expression levels of bile acid transporters are inversely correlated with the histological progression of nonalcoholic fatty liver disease.
Okushin K; Tsutsumi T; Enooku K; Fujinaga H; Kado A; Shibahara J; Fukayama M; Moriya K; Yotsuyanagi H; Koike K
J Gastroenterol; 2016 Aug; 51(8):808-18. PubMed ID: 26601667
[TBL] [Abstract][Full Text] [Related]
15. Salidroside improves high-fat diet-induced non-alcoholic steatohepatitis by regulating the gut microbiota-bile acid-farnesoid X receptor axis.
Li H; Xi Y; Xin X; Tian H; Hu Y
Biomed Pharmacother; 2020 Apr; 124():109915. PubMed ID: 31986416
[TBL] [Abstract][Full Text] [Related]
16. Flaxseed Powder Attenuates Non-Alcoholic Steatohepatitis via Modulation of Gut Microbiota and Bile Acid Metabolism through Gut-Liver Axis.
Yang C; Wan M; Xu D; Pan D; Xia H; Yang L; Sun G
Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639207
[TBL] [Abstract][Full Text] [Related]
17. Puerarin Modulates Hepatic Farnesoid X Receptor and Gut Microbiota in High-Fat Diet-Induced Obese Mice.
Yang CW; Liu HM; Chang ZY; Liu GH; Chang HH; Huang PY; Lee TY
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791314
[TBL] [Abstract][Full Text] [Related]
18. Involvement of G protein-coupled receptor kinase 2 (GRK2) in the development of non-alcoholic steatosis and steatohepatitis in mice and humans.
Cruces-Sande M; Vila-Bedmar R; Arcones AC; González-Rodríguez Á; Rada P; Gutiérrez-de-Juan V; Vargas-Castrillón J; Iruzubieta P; Sánchez-González C; Formentini L; Crespo J; García-Monzón C; Martínez-Chantar ML; Valverde ÁM; Mayor F; Murga C
Biochim Biophys Acta Mol Basis Dis; 2018 Dec; 1864(12):3655-3667. PubMed ID: 30261289
[TBL] [Abstract][Full Text] [Related]
19. Hepatic Reduction in Cholesterol 25-Hydroxylase Aggravates Diet-induced Steatosis.
Dong Z; He F; Yan X; Xing Y; Lei Y; Gao J; He M; Li D; Bai L; Yuan Z; Y-J Shyy J
Cell Mol Gastroenterol Hepatol; 2022; 13(4):1161-1179. PubMed ID: 34990887
[TBL] [Abstract][Full Text] [Related]
20. Agonist of RORA Attenuates Nonalcoholic Fatty Liver Progression in Mice via Up-regulation of MicroRNA 122.
Chai C; Cox B; Yaish D; Gross D; Rosenberg N; Amblard F; Shemuelian Z; Gefen M; Korach A; Tirosh O; Lanton T; Link H; Tam J; Permyakova A; Ozhan G; Citrin J; Liao H; Tannous M; Hahn M; Axelrod J; Arretxe E; Alonso C; Martinez-Arranz I; Betés PO; Safadi R; Salhab A; Amer J; Tber Z; Mengshetti S; Giladi H; Schinazi RF; Galun E
Gastroenterology; 2020 Sep; 159(3):999-1014.e9. PubMed ID: 32450149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]